KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (Weighted Average): 2015-2024

Historic Shares Outstanding (Weighted Average) for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $31.1 million.

  • Medpace Holdings' Shares Outstanding (Weighted Average) fell 9.38% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year decrease of 9.38%. This contributed to the annual value of $31.1 million for FY2024, which is 1.30% up from last year.
  • As of FY2024, Medpace Holdings' Shares Outstanding (Weighted Average) stood at $31.1 million, which was up 1.30% from $30.7 million recorded in FY2023.
  • In the past 5 years, Medpace Holdings' Shares Outstanding (Weighted Average) registered a high of $35.9 million during FY2021, and its lowest value of $30.7 million during FY2023.
  • For the 3-year period, Medpace Holdings' Shares Outstanding (Weighted Average) averaged around $31.0 million, with its median value being $31.1 million (2024).
  • As far as peak fluctuations go, Medpace Holdings' Shares Outstanding (Weighted Average) decreased by 13.47% in 2022, and later climbed by 1.30% in 2024.
  • Medpace Holdings' Shares Outstanding (Weighted Average) (Yearly) stood at $35.8 million in 2020, then grew by 0.47% to $35.9 million in 2021, then dropped by 13.47% to $31.1 million in 2022, then declined by 1.34% to $30.7 million in 2023, then rose by 1.30% to $31.1 million in 2024.